These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17244700)

  • 1. A new human retrovirus associated with prostate cancer.
    Fan H
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1449-50. PubMed ID: 17244700
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a retrovirus implicated in familial prostate cancer?
    Brower V
    J Natl Cancer Inst; 2009 May; 101(10):700-1. PubMed ID: 19436028
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostate cancer leads to the discovery of a new human infectious retrovirus].
    Darlix JL; Sitbon M
    Med Sci (Paris); 2007; 23(8-9):690-1. PubMed ID: 17875280
    [No Abstract]   [Full Text] [Related]  

  • 4. Is a novel human retrovirus associated with prostate cancer and chronic fatigue syndrome?
    Bannert N
    Future Microbiol; 2010 May; 5(5):689-91. PubMed ID: 20441540
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.
    Fischer N; Hellwinkel O; Schulz C; Chun FK; Huland H; Aepfelbacher M; Schlomm T
    J Clin Virol; 2008 Nov; 43(3):277-83. PubMed ID: 18823818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
    Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
    Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.
    Wang L; Mitoma J; Tsuchiya N; Narita S; Horikawa Y; Habuchi T; Imai A; Ishimura H; Ohyama C; Fukuda M
    Biochem Biophys Res Commun; 2005 Jun; 331(4):958-63. PubMed ID: 15882971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
    Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
    J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
    Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
    J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing act.
    Novak K
    Nat Rev Cancer; 2002 Feb; 2(2):80. PubMed ID: 12635168
    [No Abstract]   [Full Text] [Related]  

  • 13. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
    Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.
    Summers K; Crespi B
    Infect Genet Evol; 2008 May; 8(3):297-301. PubMed ID: 18295551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer.
    Salehi Z; Hadavi M
    J Med Virol; 2012 Sep; 84(9):1423-7. PubMed ID: 22825821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer.
    Alvarez-Cubero MJ; Entrala C; Fernandez-Rosado F; Martinez-Gonzalez LJ; Alvarez JC; Suarez A; Lorente JA; Cozar JM
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):144-9. PubMed ID: 22083266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
    Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
    Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of xenotropic murine leukemia virus-related retrovirus in chronic fatigue syndrome and prostate cancer: reach for a scorecard, not a prescription pad.
    Kearney M; Maldarelli F
    J Infect Dis; 2010 Nov; 202(10):1463-6. PubMed ID: 20936981
    [No Abstract]   [Full Text] [Related]  

  • 20. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.